Since our birth in 1920 as a pioneer in the field of hormone preparations, we have taken an important
mission directly related to life and health to heart and have made steady progress. In 2021, we shifted
to a holding company structure and took a new step toward the next 100 years. In order to contribute
to building a sustainable society by leveraging the knowledge and know-how about hormones that we have
cultivated to date as a source of growth, we have identified 17 material issues that only we can
achieve, at the same time as launching our ESG Committee in 2021. (Reorganized into 11 in October
2023 / Reorganized into 6 in April 2025)
Material Issue Identification Process
STEP1: 2021
At ASKA Pharmaceutical Holdings, in order to achieve sustainable growth for each group company,
representatives from each department (promotion officers) analyzed the current situation, along with
associated opportunities and risks, gathered opinions from members, and proposed a total of 206 issues
to the ESG promotion meeting.
The ESG Promotion Meeting summarized and classified the 206 issues proposed by the Committee of
Managers for ESG Promotion and proposed the 15 issues that should be addressed with the highest
priority to the ESG Committee.
The ESG Committee interviewed external experts and identified 17 material issues as the most important
issues and 41 associated KPIs, taking into account various guidelines and norms such as the GRI
Standards, the SDGs, the medium-term management plan, and the interests of stakeholders. In addition,
taking into account the relationship with our business and the perspective of social contribution, we
positioned "contribution to women's health" and "contribution to animal health," in particular, where
we can demonstrate our strengths, as our characteristic material issues, and after reporting to the
Board of Directors, we instructed the entire company to start initiatives in October 2021.
STEP2: 2023
Approximately 2 years after STEP1, the ideal number of material issues/KPI items, specific targets and
goals were set. In addition, as a result of discussions on reorganization at the Committee of Managers
for ESG Promotion the purpose of understanding stakeholders, in-house penetration, and raising
awareness, the reorganization into 11 material issues and 48 KPIs was proposed to the ESG Promotion
Meeting.
The ESG Promotion Meeting reviewed the content and proposed a reorganization plan consisting of 11
material issues and 48 KPIs to the ESG Committee
The ESG Committee confirmed all the proposals made by the ESG Promotion Meeting, reported them to
the Board of Directors, and then instructed the entire company to start implementing measures in
October 2023.
STEP3: 2025
In the process of implementing STEP2, the Committee of Managers for ESG Promotion reflected many of
the improvement proposals from members and proceeded with the review with efficiency and
consolidation in mind. In addition, “human rights,” which are essential
for the sustainable growth of the company and the building of trust, were newly added, and
finally, six new material issues proposals were made.
At the ESG Promotion Meeting, the Company proposed six material issues to the ESG Committee, taking
into account the following matters, which have been particularly pointed out in communication with
stakeholders.
1. Priority awareness
2. Taking advantage of the features of ASKA
3. Qualitative target ratio improvement
The ESG Committee deliberated and decided on the proposals of the ESG Promotion Committee, reported
them to the Board, and then instructed the entire company to start initiatives from April in 2025.
Sustainability Management Key Agenda Items
The Company has identified 6 “materialities” in terms of relevance to our business and
contribution to society. In particular, the Company believes that
“contributing to women's health and animal health” is a materiality in
which we can play to our strengths. The entire group will work on each item and contribute to the
achievement of the SDGs.
6 material issues identified
KPIs and SDGs for Material Issues
ESG
Materiality
KPI
SDGs
E
Promotion of Environmental Management
(1) CO2 emissions reduction: Company-wide target "60% reduction compared to
FY2013 (by FY2035)" / Domestic production site (Iwaki Factory) target "60% reduction
compared to FY2013 (by FY2030)"
(2) Reduction of total waste and maintaining/improving recycling
rate at 90% or higher: Plastic recycling rate of 65% or higher (by FY2030)
(3) Environmentally conscious business development
(4) Reduction of environmentally hazardous substance emissions (mitigation of nitrogen
load through the spread of low-protein feed)
(5) Promotion of biodiversity
(6) Thorough supply chain management and preferential purchase of environmentally friendly
products
*Limited to domestic business activities.
S
Development of Diverse Human Resources for Enhancing Corporate Value
(1) Promotion of autonomous learning (20 hours/person/year)
(2) Promotion of diverse work styles: remote work,
location-limited, shorter working hours, maintaining high & semi-high work engagement
ratio (40% or higher)
(3) Promotion of women’s participation (target for FY2029):
Female managers (20%) / Female managerial candidates (30%)
(4) Support for balancing work and life (diversity): Work
support allowance, men’s childcare leave (average 30 days or more)
(5) Annual paid leave utilization rate of 80.0% or higher
(company-wide average)
(6) Maintaining ICT environment for smooth operations inside and outside the company,
ensuring flexible working styles and productivity improvement
(7) Fostering DX talent to improve work process efficiency, thereby enhancing
organizational productivity and improving employees’ work-life balance
Contributing to Women’s Health and Animal Health
(1) Contribution to healthcare through dissemination of accurate knowledge and disease
awareness in specialty areas (obstetrics/gynecology, thyroid)
(2) Initiatives for sexual education of young people, and information dissemination on
pregnancy, childbirth, and parenting
(3) Promotion of animal welfare
(4) Development and provision of useful products for maintaining the health of companion
animals and livestock
(5) Promotion of academic activities on veterinary pharmaceuticals and related diseases
(especially reproductive/endocrine diseases)
(6) Promotion of in-house research themes and strengthening of alliance activities
Stable Supply of High-Quality Products and Proper Information Provision
(1) Strengthening value chain management
(2) Compliance with relevant laws and regulations
(3) Compliance with guidelines on promotional activities and strengthening training on
information tools for MRs, etc.
(4) Prompt provision of the latest information via the website
(5) Promotion of awareness activities for proper use among veterinary pharmaceutical users
(veterinarians, veterinary nurses, livestock producers, companion animal owners)
Respect for Human Rights
(1) Efforts toward implementing human rights due diligence based on the Human Rights
Policy
(2) Employee education and awareness-raising for proper understanding of human rights
G
Strengthening Governance
(1) Fostering a corporate culture that respects sound business ethics, and appropriate
disclosure and explanation of financial and non-financial information
(2) Ensuring substantive equality of shareholders
(3) Social contribution activities leading to solutions to social issues
(4) Constructive dialogue with stakeholders
(5) Promotion of compliance system centered on the Group Compliance Promotion Committee
(continuous implementation of preventive measures against serious incidents, etc.)
Major Material Issue Initiatives Achievements
We present the progress and achievements on the KPIs of material issues that are of particular interest
to our stakeholders. Through the ESG Committee, we continuously monitor the progress of initiatives
on
material issues and work toward further improvement.
E: Promotion of Environmental Management *Limited to domestic business activities
Corresponding SDGs
KPI
FY2025 First Half Progress
CO2 Emissions Reduction: Companywide target – 60% reduction vs FY2013 (by
FY2035) Target at domestic production site (Iwaki Factory): 60% reduction vs FY2013 (by
FY2030)
Initiatives at Iwaki Factory
(1) Introduction of solar power generation under PPA
(2) Installation of heat pumps
(3) Procurement of CO2-free electricity
(4) Commencement of operations at Community Center “arca”
(5) Completion of LED installation throughout the 3rd Formulation Building
At the companywide Energy Management Meeting, both annual and medium-to-long-term targets
were reviewed and confirmed.
(1) Annual target: Reduce energy consumption intensity by 1% or more year-on-year.
(2) Medium- to long-term target: Reduce CO2 emissions by 46% compared with
FY2013 by FY2030.
(3) Medium- to long-term target: Achieve a ratio of 50% or higher for non-fossil
electricity in total electricity use by FY2030.
For electricity equivalent to 836,753 kWh used at the head office building in FY2024,
obtained FIT Non-Fossil Certificates and Renewable Energy Certificates from the JPEX market
in May 2025 (CO2 emissions reduced by 357 t-CO2).
Reduction of Total Waste and Maintenance/Improvement of Recycling Rate of 90% or
Higher: Waste plastic recycling rate of 65% or higher (by FY2030)
Initiatives at Iwaki Factory
(1) Total waste volume: 145 t (FY2024) 42 t (FY2025 Q1), 46 t (FY2025 Q2), total
for the first half of FY2025: 88 t (of which 84 t recycled, 4 t final disposal)
ASW activities: Reconfirmed waste sorting, reduction, and recycling measures at the ASW
Leaders’ Meeting.
Initiatives at Head Office
(1) Continued efforts to prevent misprints through authentication-enabled
multifunction printers, promote paperless operations, and enforce waste separation.
Continued reuse of stationery and envelopes.
(2) Continued collection of reusable paper from office paper waste.
Environmentally Conscious Business Operations
Continued compliance with the “Environmental Conservation Agreement” concluded
with Fujisawa City and Kamakura City to maintain our environmental management framework.
At the Shonan Research Institute, prioritized introduction of non-CFC equipment for new
and renewed installations, and purchased environmentally friendly office supplies.
Initiatives at Iwaki Factory:
(1) Full-scale operation of ISO 14001 Environmental Management System began in June.
(2) Participated in the Iwaki City “Adopt Program” as part of local
volunteer activities.
(3) Reported monthly monitoring results to the Environmental Monitoring Center under
the Iwaki City Pollution Prevention Agreement, which imposes stricter standards than
national regulations.
(4) Participated in the “Iwaki Carbon Neutral Human Resource Development
Consortium.”
Initiatives by the Supply Chain Management Department: Began examining the replacement of
packaging materials (bottle and cap) with biomass-based materials.
Participated in the “28th Shonan International Village Meguri-no-Mori Tree Planting
Festival” on May 11 (11 employees joined) to enhance employees’ environmental
literacy.
Reduction of Environmentally Harmful Substances (Reduction of Nitrogen Load through Promotion
of Low-Protein Feed)
Initiatives in Animal Health Business
(1) Contributed to protein reduction in compound feed through the promotion of
L-Isoleucine.
(2) Contributed to farmland conservation through the sale of L-Lysine and other
feed-use amino acids.
Promotion of Biodiversity
Green area management of the former Kawasaki site (under company management):
(1) Conducted monthly inspections and secured perimeter access routes.
(2) Implemented heavy pruning of tall trees to prevent damage from falling trees and
to ensure safety of visitors and power lines.
(3) Conducted thinning of bamboo groves to allow sunlight penetration and protect
steep slopes by controlling undergrowth.
(4) Maintained good relations with neighboring communities through appropriate site
management and timely mowing.
Significantly improved weed control methods by shifting from post-growth mowing to the
installation of anti-weed sheets (plus five other measures).
Expressed support for the TNFD recommendations, joined the TNFD Forum, and began
disclosures aligned with the TNFD framework.
Distributed companywide training videos on biodiversity as part of the 10th AEN in April
2025 to enhance employees’ understanding of biodiversity.
Thorough Supply Chain Management and Preferential Procurement of Environmentally Friendly
Products
Initiatives by the Supply Chain Management Department:
(1) Launched the Supply Chain Checklist (including CO2 emissions status).
(2) Updated the Supply Chain web page.
(3) Developed an Environmental Packaging Assessment Sheet to establish priorities with
consideration of cost balance.
Promoted green purchasing of stationery and office supplies at the head office: Green
product purchase ratio: 63% (April–September 2025)
Clarified the position of supply chain management in the companywide value chain mapping,
with approval from the ESG Committee and the Responsible Officers’ Meeting.
S: Development of Diverse Talent to Enhance Corporate Value
Corresponding SDGs
KPI
Progress Report (First Half of FY2025)
Promoting Autonomous Learning (20 hours per employee per year)
Average learning hours per regular employee: 11.5 hours (as of the end of September)
Initiatives to encourage self-development:
(1) Conducted training for new employees on the use of Udemy and flier.
(2) Promoted the use of Udemy Business and flier through internal communications (3
Udemy News issues and 3 flier News issues).
(3) Offered elective training programs to provide autonomous learning opportunities (4
programs with 39 participants in total).
Promoted independent learning initiatives in each department, including GCP training,
English and Chinese language skill enhancement, and leadership development.
Promoting Diverse Work Styles: Remote Work, Location-Specific Roles, Shortened Working Hours /
Target Work Engagement Ratio: 40% or higher
Respected individual work–life balance by allowing employees to freely choose between
on-site and remote work.
As of the end of September: 5 employees under the Regional MR Employee System and 5 under
the Remote Work System; both systems were revised in April 2025.
Six employees utilized the short working hour system (mainly returnees from childcare
leave), enabling flexible work arrangements according to family circumstances.
Promoting Women’s Empowerment (FY2029 Targets): Ratio of Female Managers: 20% / Ratio of
Female
Manager Candidates: 30%
Held in-house roundtable discussions to share views and experiences of employees balancing
childcare and work, alongside childcare leave programs exceeding legal standards.
Conducted regular D&I training programs and enhanced the work environment to support
women’s continuous career development through life events, resulting in an increase in the
ratio of female managers to 14.1% (FY2020: 6.5%).
Initiatives for Work–Life Balance (Diversity): Work Support Incentive / Average Paternity
Leave
of 30 Days or More
Operated and promoted the “Work Support Incentive System,” compensating
employees who supported the workload of colleagues on leave (58 employees supported 17
absentees).
Established a dedicated consultation desk and internal portal to alleviate concerns
regarding long-term childcare leave. Promoted paternity leave, resulting in an increase in
average leave days (First Half of FY2025: 31.2 days; FY2024: 16.28 days).
Paternity leave acquisition rate: 100% (10 male employees took leave for 8 childbirths).
Seven employees took more than one month of leave, with guidance provided to all managers to
encourage and facilitate leave acquisition (100% implementation).
Annual Paid Leave Utilization Rate: 80% or Higher (Company-Wide Average)
Annual paid leave utilization rate: 44.7% (Managers: 41.6%, Staff: 46.3%, as of the end of
September). Communicated company-wide the FY2025 target of achieving 80% or higher
utilization as part of workstyle guidelines.
Maintaining an Effective ICT Environment to Facilitate Flexible Work and Enhance Productivity
Supply Chain Management Department conducted “Planner” study sessions based on
feedback from DX promotion activities.
Network environment renewal, scheduled for activation in the second half, is expected to
enhance access speed and security. Improved iPhone communication performance will also
strengthen tethering connections.
Developing Digital Transformation (DX) Talent to Improve Operational Efficiency,
Organizational Productivity, and Work–Life Balance
Introduced a training program for new employees utilizing generative AI to learn about the
company’s history and business development, fostering a foundation for DX capabilities.
Provided internal education on AI/RPA and related technologies, disseminating information
to strengthen digital literacy and promote DX talent development, thereby enhancing
productivity and operational efficiency.
S: Contributing to Women’s Health and Animal Health
Relevant SDGs
KPI
Progress Report for the First Half of FY2025
Contribution to Healthcare through Disease Awareness and Dissemination of Accurate Knowledge
in Specialty Areas (Obstetrics & Gynecology, Thyroid Disorders)
Endocrinology Business Promotion Office: Published an article on thyroid disease awareness
in the April–May issue of Metropolitana, an information magazine by Sankei Shimbun.
Conducted a web seminar for municipal health promotion officers on women’s life
stage-specific health issues, focusing on female and thyroid hormones, among other
initiatives.
Shonan CMC: Progressed development of three gynecology products toward market launch,
including obtaining approval for LF111 (Sulinda Tablets 28).
Sales Division: Provided appropriate usage information through national and regional
seminars on topics such as hepatic encephalopathy and contraception (15 national lectures,
41 regional sessions, 13 or more co-sponsored seminars).
Held the ASKA Media Seminar to promote awareness and understanding of new contraceptive
options, reaching 54 media representatives and investors, and featured in publications such
as Yakujinippo, Answers News, Iji Shinpo, and Mizuho
Securities reports.
Hosted the “Mint Meeting – Voices that Empower Women” on June 25, engaging
approximately 50 women in their 20s–30s to share accurate information on women’s health and
the importance of gynecological consultation.
Initiatives for Providing Information on Sex Education and Reproductive Health from
Adolescence through Childrearing
Exhibited informational booklets on contraception and emergency contraception at
“Seminars on Contraception and STI Prevention for Educators” (2 events, approx.
300 participants).
Added new content on contraception and preconception care to the “Mint+
Teens” website, and continued outreach to younger audiences via 27 Instagram posts.
Distributed 170,040 copies of the supplementary educational booklet “What High
School Students Should Know About Sexual Health” free of charge to 411 high schools
across Japan.
Promotion of Animal Welfare
Shonan Research Institute initiatives:
(1) Published ethical considerations for research on the corporate website.
(2) Conducted animal experiments in compliance with in-house regulations and Shonan
iPark Animal Experiment Rules, within AAALAC-accredited facilities.
(3) Participated in the Shonan iPark Animal Memorial Service held on September 11.
Contributed to animal welfare through the development, manufacture, and sale of veterinary
pharmaceuticals, feed additives, and supplements.
Development and Provision of Products Contributing to the Health of Companion and Livestock
Animals
Submitted an application for manufacturing and marketing approval of an endocrine drug for
dogs.
Obtained approvals and made necessary changes to ensure a stable supply of products for
companion and livestock animals.
Promotion of Academic Activities Related to Veterinary Medicines and Associated Diseases
(Especially Reproductive and Endocrine Disorders)
Produced an educational video on Cushing’s syndrome associated with Trilostane Tablets
“ASKA,” featuring academic experts.
Promotion of In-house Research Themes and Strengthening of Alliance Activities
Shonan Research Institute initiatives:
(1) Actively leveraged open innovation to explore new research areas.
(2) Introduced foundational drug discovery technologies targeting ion channels.
(3) Conducted a public call for joint drug discovery research targeting academic and
public-sector researchers in Japan.
International Business Division: Promoted the search for new potential partners in
Southeast Asia.